It's all going to add up. Estimate of $300K fees with the previous two for 2018, and double that and quickly its $600K net. The more business the better, obviously the 2 contracts have had a huge impact on gross revenues and fees received already. Not to mention it is a Gateway for those patients to use PharmcoRX as their pharmacy for all medications, those not under 340B. As a businessman these things should seem obvious.
“Through these new 340B contractual relationships, Progressive Care can illustrate the need for advanced pharmacy services for vulnerable high-risk populations,” said S. Parikh Mars, CEO of Progressive Care Inc. “340B programs have had a positive impact on communities, while allowing the company to diversify and benefit from our proactive patient engagement and risk management models. We believe that success of our initiatives will lead to more opportunities like these to enhance our growth and execute our overall mission.”
The 340B Drug Discount Program is a United States federal government program that allows certain non-profit and charitable healthcare institutions to purchase medications at a reduced price. These entities can contract with pharmacies to provide prescription services to their patients. Contracted pharmacies support the program by acting as a pass through and providing the much-needed adherence monitoring and pharmacological expertise, the compensation for which is commensurate with standard profitability for 340B covered drugs.
"To Give Anything Less Than Your Best, Is To Sacrifice the Gift." - Steve Prefontaine
